menu search

Bitcoin and ethereum fail to talk off as us debt ceiling talks stall

Bitcoin and Ethereum failed to take off despite US debt ceiling talks stuttering. The largest coin by m...

May 22, 2023, 8:44 am

Micron's stock falls after china ban. here's why gauging the impact isn't so simple.

Micron Technology Inc. shares were falling 4% in premarket trading Monday as Wall Street tried to determine the future impact of a ...

May 22, 2023, 7:49 am

Factbox: the jpmorgan executives who will update investors on first republic, strategy

JPMorgan Chase & Co executives will update investors on its takeover of failed First Republic Bank, whi...

May 22, 2023, 6:31 am

Stock market live: asian equities under pressure as us debt talks cast shadow

Stocks are primed to drop if the US fails to raise the debt limit and delays government payments. Meanw...

May 22, 2023, 2:29 am

Crude oil price creates a range after failing to gain. where to for wti?

Crude oil prices consolidated into the week as the US Dollar appears vulnerable with debt ceiling uncertainty lingering and the possibility of the Fed...

May 22, 2023, 2:00 am

China bars purchases of micron chips

China has delivered its latest salvo in its semiconductor battle with the US, barring the operators of key infrastructure from buying Micron chips aft...

May 21, 2023, 10:04 pm

China bans micron products, cites "significant security risks" to "national security"

China's cyberspace regulator banned products made by U.S. memory chip manufacturer Micron Technology from use in key infrastructure. The chip ban coul...

May 21, 2023, 8:17 pm

Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:05 pm

Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:05 pm

Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:05 pm

Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:05 pm

Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:00 pm

Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:00 pm

Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:00 pm

Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:00 pm

Jpmorgan may turn first republic sites into 'special branches' for wealthy clients, report says

JPMorgan Chase bought the San Francisco-based First Republic Bank on May 1 after it failed. The Wall St...

May 21, 2023, 12:00 pm

Wife finds husband’s bitcoin stash amid divorce proceedings

The woman appointed a forensic accountant, who eventually found that the husband failed to declare 12 B...

May 21, 2023, 8:29 am

Drug absorption in the management of congestive heart failure: loop diuretics

Disease states like CHF that slow the rate of diuretic absorption are common causes of unpredictable diuretic responses. This occurrence is common whe...

May 21, 2023, 3:14 am

Usdcad weekly analysis – may 21, 2023

The USDCAD currency pair has recently displayed resilience as it failed to break below the rising price...

May 21, 2023, 3:11 am

Nyc pension funds lose $2m in failed first republic, signature banks

City pension funds had almost $2 million invested with First Republic Bank and Signature Bank -- all of which was lost when the banks ...

May 20, 2023, 12:37 pm


Search within

Pages Search Results: